211 related articles for article (PubMed ID: 37119758)
1. House dust mite allergy: The importance of house dust mite allergens for diagnosis and immunotherapy.
Huang HJ; Sarzsinszky E; Vrtala S
Mol Immunol; 2023 Jun; 158():54-67. PubMed ID: 37119758
[TBL] [Abstract][Full Text] [Related]
2. The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis.
Zhao L; Zhang Y; Zhang S; Zhang L; Lan F
Expert Rev Clin Immunol; 2021 Sep; 17(9):969-975. PubMed ID: 34388949
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
Huang HH; Xu C; Liu L; Chai RN
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
[No Abstract] [Full Text] [Related]
4. Recombinant house dust mite allergens.
Vrtala S; Huber H; Thomas WR
Methods; 2014 Mar; 66(1):67-74. PubMed ID: 23911838
[TBL] [Abstract][Full Text] [Related]
5. Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.
Batard T; Baron-Bodo V; Martelet A; Le Mignon M; Lemoine P; Jain K; Mariano S; Horiot S; Chabre H; Harwanegg C; Marquette CA; Corgier BP; Soh WT; Satitsuksanoa P; Jacquet A; Chew FT; Nony E; Moingeon P
Allergy; 2016 Feb; 71(2):220-9. PubMed ID: 26485347
[TBL] [Abstract][Full Text] [Related]
6. Correlation between sensitization to house dust mite major allergens, age, and symptoms in Japanese house dust mite allergic subjects.
Hasegawa A; Utsumi D; Lund K; Okano M; Ohashi-Doi K; Okubo K
Int Immunopharmacol; 2022 Jun; 107():108640. PubMed ID: 35217338
[TBL] [Abstract][Full Text] [Related]
7. Impact of Dermatophagoides pteronyssinus mite body raw material on house dust mite allergy diagnosis in a Serbian population.
Burazer L; Milovanovic K; Milovanovic M; Vuckovic O; Velickovic TC; Gavrovic-Jankulovic M
Med Vet Entomol; 2011 Mar; 25(1):77-83. PubMed ID: 20819152
[TBL] [Abstract][Full Text] [Related]
8. Sensitization to various minor house dust mite allergens is greater in patients with atopic dermatitis than in those with respiratory allergic disease.
Park KH; Lee J; Lee JY; Lee SC; Sim DW; Shin JU; Park CO; Lee JH; Lee KH; Jeong KY; Park JW
Clin Exp Allergy; 2018 Aug; 48(8):1050-1058. PubMed ID: 29700921
[TBL] [Abstract][Full Text] [Related]
9. House dust mite allergy: Its innate immune response and immunotherapy.
Huang FL; Liao EC; Yu SJ
Immunobiology; 2018 Mar; 223(3):300-302. PubMed ID: 29079219
[TBL] [Abstract][Full Text] [Related]
10. Asthma, Airway Symptoms and Rhinitis in Office Workers in Malaysia: Associations with House Dust Mite (HDM) Allergy, Cat Allergy and Levels of House Dust Mite Allergens in Office Dust.
Lim FL; Hashim Z; Than LT; Md Said S; Hisham Hashim J; Norbäck D
PLoS One; 2015; 10(4):e0124905. PubMed ID: 25923543
[TBL] [Abstract][Full Text] [Related]
11. IgE recognition of the house dust mite allergen Der p 37 is associated with asthma.
Huang HJ; Resch-Marat Y; Casset A; Weghofer M; Zieglmayer P; Zieglmayer R; Lemell P; Horak F; Chen KW; Potapova E; Matricardi PM; Pauli G; Grote M; Valenta R; Vrtala S
J Allergy Clin Immunol; 2022 Mar; 149(3):1031-1043. PubMed ID: 34419535
[TBL] [Abstract][Full Text] [Related]
12. Allergen desensitization reduces the severity of relapsed alopecia areata in dust-mite allergic patients.
Zeng Z; Li S; Ye Y; Ling Y; Gong Y; Zi X; Yang J; McElwee KJ; Zhang X
Exp Dermatol; 2023 Jul; 32(7):1108-1119. PubMed ID: 37114716
[TBL] [Abstract][Full Text] [Related]
13. Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy.
Kiatiwat P; Sangasapaviliya A; Pradubpongsa P; Sangkanjanavanich S; Chiewchalermsri C; Jacquet A; Jaisupa N; Jindarat S; Boonpiyathad T; Mitthamsiri W
Allergy; 2023 Jul; 78(7):2019-2021. PubMed ID: 36754574
[No Abstract] [Full Text] [Related]
14. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
[TBL] [Abstract][Full Text] [Related]
15. Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy.
Bouaziz A; Walgraffe D; Bouillot C; Herman J; Foguenne J; Gothot A; Louis R; Hentges F; Jacquet A; Mailleux AC; Chevigné A; Galleni M; Adam E; Dumez ME
Clin Exp Allergy; 2015 Apr; 45(4):823-34. PubMed ID: 25406386
[TBL] [Abstract][Full Text] [Related]
16. [Molecular diagnostic strategies and management of dust mite allergy].
Gan H; Wu LT; Sun BQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Jan; 58(1):148-154. PubMed ID: 38228563
[TBL] [Abstract][Full Text] [Related]
17. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
[TBL] [Abstract][Full Text] [Related]
18. House dust mite allergy in Malaysia: review of research gaps in the current scenario and the way forward.
Lee YZ; Kow ASF; Jacquet A; Lee MT; Tham CL
Exp Appl Acarol; 2023 Dec; 91(4):509-539. PubMed ID: 37995026
[TBL] [Abstract][Full Text] [Related]
19. Molecular Profile Sensitization to House Dust Mites as an Important Aspect for Predicting the Efficiency of Allergen Immunotherapy.
Rodinkova VV; Yuriev SD; Kryvopustova MV; Mokin VB; Kryzhanovskyi YM; Kurchenko AI
Front Immunol; 2022; 13():848616. PubMed ID: 35392080
[TBL] [Abstract][Full Text] [Related]
20. Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling.
Batard T; Canonica WG; Pfaar O; Shamji MH; O'Hehir RE; van Zelm MC; Mascarell L
Mol Immunol; 2023 Mar; 155():124-134. PubMed ID: 36806944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
